First case report of de novo ulcerative colitis developing after orthotopic liver transplantation successfully treated by granulocyte and monocyte apheresis

Transplantation Proceedings

Volumn 46, Issue 7, 2014, Pages 2414-2417

  Ihara, S ^a   Yamaji, Y ^a   Kinoshita, H ^a   Yamada, A ^a   Hirata, Y ^a   Hasegawa, K ^a   Sugawara, Y ^a   Kokudo, N ^a   Koike, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; ENTECAVIR; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEVOFLOXACIN; MESALAZINE; METHYLPREDNISOLONE; TACROLIMUS; VANCOMYCIN;

ADULT; APHERESIS; ARTICLE; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COLONOSCOPY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; GRANULOCYTE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MONOCYTE; RELAPSE; REMISSION; TREATMENT RESPONSE; ULCERATIVE COLITIS; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; COLITIS, ULCERATIVE; COMPLICATION; LEUKAPHERESIS; LIVER NEOPLASMS; MIDDLE AGED; MONONUCLEAR CELL; PROCEDURES; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; COLITIS, ULCERATIVE; GRANULOCYTES; HEPATITIS B; HUMANS; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 84908151869     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.02.016     Document Type: Article

References (27)

1. A. Sandhu, T. Alameel, and C. Dale The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series Aliment Pharmacol Ther 36 2012 159 165
2. U. Navaneethan, M. Choudhary, and P. Venkatesh The effects of liver transplantation on the clinical course of colitis in ulcerative colitis patients with primary sclerosing cholangitis Aliment Pharmacol Ther 35 2012 1054 1063
3. M. Wörns, A. Lohse, and M. Neurath Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation Am J Gastroenterol 101 2006 1931 1937
4. A. Kornbluth, and D. Sachar Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee Am J Gastroenterol 105 2010 501 523
5. C. Mowat, A. Cole, and A. Windsor Guidelines for the management of inflammatory bowel disease in adults Gut 60 2011 571 607
6. S.P.L. Travis, E.F. Stange, and M. Lemann European evidence-based consensus on the management of ulcerative colitis: current management J Crohns Colitis 2 2008 24 62
7. A. Pan, M. Schlup, and R. Lubckea Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review J Crohns Colitis 5 2011 465 468
8. B. Habermalz, and S. Sauerland Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis Dig Dis Sci 55 2010 1421 1428
9. M. Vecchi, P. Vernia, and G. Riegler Therapeutic landscape for ulcerative colitis: where is the Adacolumn system and where should it be? Clin Exp Gastroenterol 6 2013 1 7
10. T. Shimoyama, K. Sawada, and N. Hiwatashi Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study J Clin Apher 16 2001 1 9
11. W. Kruis, A. Dignass, and E. Steinhagen-Thiessen Open-label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis World J Gastroenterol 11 2005 7001 7006
12. T. Yoshino, H. Nakase, and M. Matsuura Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants Digestion 84 2011 3 9
13. G. Novelli, M. Rossi, and V. Morabito Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis Transplant Proc 44 2012 1946 1952
14. K.J. Moncrief, A. Savu, and M.M. Ma The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation - a single-centre experience Can J Gastroenterol 24 2010 40 46
15. P. Ginsburg, and P. Thuluvath Diarrhea in liver transplant recipients: etiology and management Liver Transpl 8 2005 881 890
16. N.A. Wong, A.J. Bathgate, and C.O. Bellamy Colorectal disease in liver allograft recipients: a clinicopathological study with follow-up Eur J Gastroenterol Hepatol 14 2002 231 236
17. T. Sakamoto, Y. Sato, and S. Yamamoto De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report Transplant Proc 44 2012 570 573
18. A.N. Ananthakrishnan, M. Issa, and D.G. Binion Clostridium difficile and inflammatory bowel disease Gastroenterol Clin North Am 38 2009 711 728
19. S. Wang, Z. Wang, and C. Yang Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease Exp Ther Med 4 2012 1051 1056
20. M. Esteve, C. Saro, and F. Gonzalez-Huix Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis Gut 53 2004 1363 1365
21. S. Mukherjee A review of hepatitis B management in pre- and post-liver transplant recipients Open Immunol J 3 2010 27 35
22. N. Kashiwagi, I. Hirata, and R. Kasukawa A role of granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis Ther Apher 2 1998 134 141
23. K. Fukunaga, and T. Matsumoto Current status and future perspectives of leukocytapheresis for inflammatory bowel disease J Gastroenterol Hepatol 27 2012 997 1003
24. B.E. Sands, W.J. Sandborn, and B. Feagan A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis Gastroenterology 135 2008 400 409
25. S. Passalacqua, P.M. Ferraro, and G. Bresci The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study J Clin Apher 26 2011 332 337
26. L. Maiden, K. Takeuchi, and R. Baur Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse Inflamm Bowel Dis 14 2008 1413 1418
27. J.L. Cabriada, N. Ibargoyen, and A. Hernández Sustained remission after steroids and leukocyte- apheresis induced response in steroid-dependent ulcerative colitis: results at 1 year Dig Liver Dis 42 2010 432 435